Skip to main contentSkip to navigationSkip to search

Pandox’s CEO Anders Nissen is undergoing medical treatment

21 May, 2021, 13:30
Regulatory information
Pandox AB (publ) CEO Anders Nissen is currently undergoing medical treatment due to Covid-19. After treatment, an additional rehabilitation period may be required before Anders Nissen can return to full employment. Against this background, Pandox’s board of directors has today decided to appoint the company’s CFO, Liia Nõu, as acting CEO during this period.


Christian Ringnes, Chairman of the board of directors, +47 22 33 05 50
Liia Nõu, CFO, +46 (0) 702 37 44 04 
Anders Berg, Head of Communications and IR, +46 (0) 760 95 19 40

This information is information that Pandox AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above 21 May 2021, 13:30 CEST.

About Pandox
Pandox is a leading owner of hotel properties in Northern Europe with a focus on sizeable hotels in key leisure and corporate destinations. Pandox’s hotel property portfolio currently comprises 156 hotels with approximately 35,000 hotel rooms in 15 countries. Pandox’s business is organised into Property management, which comprises hotel properties leased on a long-term basis to market leading regional hotel operators and leading international hotel operators, and Operator activities, which comprises hotel operations executed by Pandox in its owner-occupied hotel properties. Pandox was founded in 1995 and the company’s B shares are listed on Nasdaq Stockholm.